[Osteopathies, calcium- and vitamin D metabolism errors during anti-epileptic long term therapy].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000927:Anticonvulsants / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001847:Bone Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control; D002648:Child; D002675:Child, Preschool; D002762:Cholecalciferol / Q000097:blood; D003937:Diagnosis, Differential; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced*; D007223:Infant; D008297:Male; D008875:Middle Aged; D010018:Osteomalacia / Q000139:chemically induced; D010710:Phosphates / Q000097:blood; D012279:Rickets / Q000139:chemically induced / Q000175:diagnosis; D013997:Time Factors; D014807:Vitamin D / Q000627:therapeutic use; D014808:Vitamin D Deficiency / Q000139:chemically induced*
D000927:Anticonvulsants; D010710:Phosphates; D014807:Vitamin D; D002762:Cholecalciferol; D000469:Alkaline Phosphatase
Osteopathien, Kalzium- and Vitamin-D-Stoffwechselstörungen unter antiepileptischer Langzeittherapie